lung and pleural cancer; lung and pleural cancer; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from medical information team. this is one of two reports. this report is for the first dose. a male patient received bnt162b2 (comirnaty), administration date mar2021 (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: lung neoplasm malignant (medically significant), pleural neoplasm (medically significant) all with onset may2021, outcome "unknown" and all described as "lung and pleural cancer". the lot number for bnt162b2 was not provided and will be requested during follow up.; sender's comments: linked report(s) : it-pfizer inc-202200274906 same source, same patient,same drug; different event at a difefrent dose